{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:58:09Z","timestamp":1790701089483,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100019122","name":"Fondation Raoul Follereau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019122","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.cmi.2021.07.007","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T02:26:27Z","timestamp":1626143187000},"page":"1601-1612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["A systematic review of Mycobacterium leprae DNA gyrase mutations and their impact on fluoroquinolone resistance"],"prefix":"10.1016","volume":"27","author":[{"given":"Aur\u00e9lie","family":"Chauffour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Reibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Petrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Cambau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2021.07.007_bib1","first-page":"417","article-title":"Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives","volume":"95","year":"2020","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.cmi.2021.07.007_bib2","series-title":"Guidelines for the diagnosis, treatment and prevention of leprosy","year":"2017"},{"key":"10.1016\/j.cmi.2021.07.007_bib3","first-page":"6","article-title":"Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea","volume":"50","author":"You","year":"2005","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2021.07.007_bib4","first-page":"10","article-title":"The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines","volume":"78","author":"Matsuoka","year":"2007","journal-title":"Lepr Rev"},{"key":"10.1016\/j.cmi.2021.07.007_bib5","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.cmi.2018.02.022","article-title":"Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009\u201315","volume":"24","author":"Cambau","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.07.007_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.112.3.445","article-title":"The experimental disease that follows the injection of human leprosy bacilli into foot-pads of mice","volume":"112","author":"Shepard","year":"1960","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cmi.2021.07.007_bib7","doi-asserted-by":"crossref","first-page":"e1739","DOI":"10.1371\/journal.pntd.0001739","article-title":"Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test","volume":"6","author":"Cambau","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2021.07.007_bib8","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/35059006","article-title":"Massive gene decay in the leprosy bacillus","volume":"409","author":"Cole","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.cmi.2021.07.007_bib9","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1128\/AAC.00707-11","article-title":"DNA Gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis","volume":"55","author":"Pantel","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2021.07.007_bib10","first-page":"259","article-title":"Activity of ofloxacin against Mycobacterium leprae in the mouse","volume":"56","author":"Grosset","year":"1988","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.cmi.2021.07.007_bib11","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/AAC.38.4.662","article-title":"Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy","volume":"38","author":"Ji","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2021.07.007_bib12","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1128\/AAC.01162-07","article-title":"Powerful bactericidal activity of moxifloxacin in human leprosy","volume":"52","author":"Pardillo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2021.07.007_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(05)60888-4","article-title":"Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae","volume":"349","author":"Cambau","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2021.07.007_bib14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/AAC.04058-14","article-title":"Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis","volume":"59","author":"Bernard","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2021.07.007_bib15","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1016\/j.csbj.2020.11.013","article-title":"HARP: a database of structural impacts of systematic missense mutations in drug targets of Mycobacterium leprae","volume":"18","author":"Vedithi","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.cmi.2021.07.007_bib16","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1128\/AAC.01282-06","article-title":"Expression and Purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones","volume":"51","author":"Matrat","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2021.07.007_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1086\/324623","article-title":"Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy","volume":"34","author":"Cambau","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2021.07.007_bib18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/AAC.01095-07","article-title":"Are all the DNA gyrase mutations found in mycobacterium leprae clinical strains involved in resistance to fluoroquinolones?","volume":"52","author":"Matrat","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2021.07.007_bib19","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1099\/00221287-148-10-2967","article-title":"Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv","volume":"148","author":"M\u00e9digue","year":"2002","journal-title":"Microbiology"},{"key":"10.1016\/j.cmi.2021.07.007_bib20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","article-title":"The Phyre2 web portal for protein modeling, prediction and analysis","volume":"10","author":"Kelley","year":"2015","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cmi.2021.07.007_bib21","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1038\/s41467-019-12914-y","article-title":"Cryo-EM structure of the complete E. coli DNA gyrase nucleoprotein complex","volume":"10","author":"Vanden Broeck","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2021.07.007_bib22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1471-2105-13-224","article-title":"Improved model quality assessment using ProQ2","volume":"13","author":"Ray","year":"2012","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.cmi.2021.07.007_bib23","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1073\/pnas.1525047113","article-title":"Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis","volume":"113","author":"Blower","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cmi.2021.07.007_bib24","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1128\/AAC.45.12.3635-3639.2001","article-title":"Multidrug Resistant Mycobacterium leprae from patients with leprosy","volume":"45","author":"Maeda","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2021.07.007_bib25","first-page":"121","article-title":"Mycobacterium leprae typing by genomic diversity and global distribution of genotypes","volume":"68","author":"Matsuoka","year":"2000","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.cmi.2021.07.007_bib26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1489\/1544-581X(2003)71<240:ASCOMM>2.0.CO;2","article-title":"A\u00a0second case of multidrug-resistant Mycobacterium leprae isolated from a Japanese patient with relapsed lepromatous leprosy","volume":"71","author":"Matsuoka","year":"2003","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.cmi.2021.07.007_bib27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/infdis\/170.2.479","article-title":"Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin","volume":"170","author":"Cambau","year":"1994","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2021.07.007_bib28","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/dkr566","article-title":"A\u00a0systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system","volume":"67","author":"Maruri","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2021.07.007_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02576-z","article-title":"Phylogenomics and antimicrobial resistance of the leprosy bacillus Mycobacterium leprae","volume":"9","author":"Benjak","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2021.07.007_bib30","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1073\/pnas.93.8.3410","article-title":"Homing events in the gyrA gene of some mycobacteria","volume":"93","author":"Fsihi","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cmi.2021.07.007_bib31","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1128\/AAC.06272-11","article-title":"Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in","volume":"56","author":"Pantel","year":"2012","journal-title":"M\u00a0tuberculosis Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2021.07.007_bib32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4269\/ajtmh.19-0390","article-title":"Evidence for Mycobacterium leprae drug resistance in a large cohort of leprous neuropathy patients from India","volume":"102","author":"Mahajan","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2021.07.007_bib33","doi-asserted-by":"crossref","first-page":"724","DOI":"10.4269\/ajtmh.19-0905","article-title":"Case report: multidrug-resistant Mycobacterium leprae in a case of smear-negative relapse","volume":"102","author":"Kamat","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2021.07.007_bib34","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/ced.12665","article-title":"Drug resistance in Mycobacterium leprae from patients with leprosy in China","volume":"40","author":"Liu","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.cmi.2021.07.007_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7705\/biomedica.v34i0.1686","article-title":"Es la resistencia de Mycobacterium leprae a los medicamentos un verdadero motivo de preocupaci\u00f3n? Primera aproximaci\u00f3n a la vigilancia molecular de pacientes colombianos multibacilares con tratamiento previo para lepra y sin \u00e9l","volume":"34","author":"Guerrero","year":"2013","journal-title":"Biomedica"},{"key":"10.1016\/j.cmi.2021.07.007_bib36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4103\/ijdvl.IJDVL_34_16","article-title":"Resistance to anti leprosy drugs in multi-bacillary leprosy: a cross sectional study from a tertiary care centre in eastern Uttar Pradesh, India","volume":"84","author":"Singh","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.cmi.2021.07.007_bib37","doi-asserted-by":"crossref","first-page":"1213.e5","DOI":"10.1016\/j.cmi.2018.06.004","article-title":"Prospective study on antimicrobial resistance in leprosy cases diagnosed in France from 2001 to 2015","volume":"24","author":"Chauffour","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.07.007_bib38","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1099\/jmm.0.029389-0","article-title":"Genotyping of Mycobacterium leprae from Brazilian leprosy patients suggests the occurrence of reinfection or of bacterial population shift during disease relapse","volume":"60","author":"da Silva Rocha","year":"2011","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.cmi.2021.07.007_bib39","first-page":"1","article-title":"A\u00a0case of fluoroquinolone-resistant leprosy discovered after 9 years of misdiagnosis","volume":"2016","author":"Raharolahy","year":"2016","journal-title":"Case Rep Infect Dis"},{"key":"10.1016\/j.cmi.2021.07.007_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007946","article-title":"Nested PCR and the TaqMan SNP Genotyping Assay enhanced the sensitivity of drug resistance testing of Mycobacterium leprae using clinical specimens of leprosy patients","volume":"13","author":"Chen","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2021.07.007_bib41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.47276\/lr.85.3.177","article-title":"Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending the Leprosy Mission (TLM) Hospitals in India","volume":"85","author":"Lavania","year":"2014","journal-title":"Lepr Rev"},{"key":"10.1016\/j.cmi.2021.07.007_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005041","article-title":"Leprosy drug resistance surveillance in Colombia: the experience of a sentinel country","volume":"10","author":"Beltr\u00e1n-Alzate","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2021.07.007_bib43","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1080\/22221751.2019.1677177","article-title":"Molecular surveillance of antimicrobial resistance and transmission pattern of Mycobacterium leprae in Chinese leprosy patients","volume":"8","author":"Chokkakula","year":"2019","journal-title":"Emerg Microbe. Infect"},{"key":"10.1016\/j.cmi.2021.07.007_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0928-8244(03)00038-5","article-title":"Detection of gene mutations related with drug resistance in Mycobacterium leprae from leprosy patients using Touch-Down (TD) PCR","volume":"36","author":"Kim","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.cmi.2021.07.007_bib45","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1128\/AAC.40.8.1768","article-title":"Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra","volume":"40","author":"Kocag\u00f6z","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2021.07.007_bib46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1128\/AAC.50.1.104-112.2006","article-title":"Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes","volume":"50","author":"Aubry","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2021.07.007_bib47","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1099\/00221287-148-10-2967","article-title":"Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv","volume":"148","author":"Camus","year":"2002","journal-title":"Microbiology"},{"key":"10.1016\/j.cmi.2021.07.007_bib48","first-page":"830","article-title":"Drug susceptibility testing of Mycobacterium leprae","volume":"55","author":"Baohong","year":"1987","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.cmi.2021.07.007_bib49","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1128\/AAC.48.4.1281-1288.2004","article-title":"Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity","volume":"48","author":"Aubry","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2021.07.007_bib50","doi-asserted-by":"crossref","first-page":"e1838","DOI":"10.1371\/journal.pntd.0001838","article-title":"Impact of amino acid substitutions in B subunit of DNA gyrase in Mycobacterium leprae on fluoroquinolone resistance","volume":"6","author":"Yokoyama","year":"2012","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.cmi.2021.07.007_bib62","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/AAC.38.4.773","article-title":"Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations","volume":"38","author":"Takiff","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2021.07.007_bib63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/24206","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"396","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.cmi.2021.07.007_bib64","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1086\/315708","article-title":"Selection of Antibiotic-Resistant Bacterial Mutants: Allelic Diversity among Fluoroquinolone-Resistant Mutations","volume":"182","author":"Zhou","year":"2000","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.cmi.2021.07.007_bib65","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jgar.2017.10.010","article-title":"Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients","volume":"12","author":"Lavania","year":"2018","journal-title":"Journal of Global Antimicrobial Resistance"},{"key":"10.1016\/j.cmi.2021.07.007_bib66","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1128\/JCM.01688-14","article-title":"Identification of Primary Drug Resistance to Rifampin in Mycobacterium leprae Strains from Leprosy Patients in Amazonas State, Brazil","volume":"52","author":"Contreras Mejia","year":"2014","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.cmi.2021.07.007_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005506","article-title":"qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients Walson JL","volume":"11","author":"Araujo","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2021.07.007_bib68","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5025\/hansen.79.247","article-title":"The history and characteristics of isolates maintained at the Leprosy Research Center","volume":"79","author":"Matsuoka","year":"2010","journal-title":"Japanese Journal of Leprosy"},{"key":"10.1016\/j.cmi.2021.07.007_bib69","first-page":"ciz570","article-title":"Emergence and Transmission of Drug-\/Multidrug-resistant Mycobacterium leprae in a Former Leprosy Colony in the Brazilian Amazon","author":"Rosa","year":"2019","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.cmi.2021.07.007_bib70","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/AAC.05890-11","article-title":"Amino Acid Substitutions at Position 95 in GyrA Can Add Fluoroquinolone Resistance to Mycobacterium leprae","volume":"56","author":"Yokoyama","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2021.07.007_bib71","first-page":"10","article-title":"DC-159a Shows Inhibitory Activity against DNA Gyrases of Mycobacterium leprae","author":"Yamaguchi","year":"2016","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X21003815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X21003815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:29:15Z","timestamp":1761118155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X21003815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1198743X21003815"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2021.07.007","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of Mycobacterium leprae DNA gyrase mutations and their impact on fluoroquinolone resistance","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2021.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}